BR112018001736A2 - ?composição farmacêutica com micela polimérica? - Google Patents

?composição farmacêutica com micela polimérica?

Info

Publication number
BR112018001736A2
BR112018001736A2 BR112018001736A BR112018001736A BR112018001736A2 BR 112018001736 A2 BR112018001736 A2 BR 112018001736A2 BR 112018001736 A BR112018001736 A BR 112018001736A BR 112018001736 A BR112018001736 A BR 112018001736A BR 112018001736 A2 BR112018001736 A2 BR 112018001736A2
Authority
BR
Brazil
Prior art keywords
quot
pharmaceutical composition
polymeric micelle
micelle
polymeric
Prior art date
Application number
BR112018001736A
Other languages
English (en)
Portuguese (pt)
Inventor
Oh Kim Bong
Chan MIN Bum
Rim Kim Hye
Ja Choi In
Yeong KIM Ji
Woong Cho Joong
Hyo Seo Min
Won Lee Sa
Woong Yi Yil
Original Assignee
Samyang Biopharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Biopharmaceuticals filed Critical Samyang Biopharmaceuticals
Publication of BR112018001736A2 publication Critical patent/BR112018001736A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/88Post-polymerisation treatment
    • C08G63/90Purification; Drying
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66Polyesters containing oxygen in the form of ether groups
    • C08G63/664Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/78Preparation processes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/78Preparation processes
    • C08G63/82Preparation processes characterised by the catalyst used
    • C08G63/823Preparation processes characterised by the catalyst used for the preparation of polylactones or polylactides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/78Preparation processes
    • C08G63/82Preparation processes characterised by the catalyst used
    • C08G63/85Germanium, tin, lead, arsenic, antimony, bismuth, titanium, zirconium, hafnium, vanadium, niobium, tantalum, or compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BR112018001736A 2015-07-28 2016-07-28 ?composição farmacêutica com micela polimérica? BR112018001736A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20150106626 2015-07-28
PCT/KR2016/008265 WO2017018816A1 (en) 2015-07-28 2016-07-28 Pharmaceutical composition with improved storage stability and method for preparing the same

Publications (1)

Publication Number Publication Date
BR112018001736A2 true BR112018001736A2 (pt) 2018-09-11

Family

ID=57884841

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018001736A BR112018001736A2 (pt) 2015-07-28 2016-07-28 ?composição farmacêutica com micela polimérica?

Country Status (13)

Country Link
EP (1) EP3328434A4 (ja)
JP (1) JP6605706B2 (ja)
KR (1) KR101748191B1 (ja)
CN (2) CN111574702A (ja)
AU (1) AU2016299544A1 (ja)
BR (1) BR112018001736A2 (ja)
CA (1) CA2993920A1 (ja)
HK (1) HK1249439A1 (ja)
IL (1) IL257185A (ja)
MX (1) MX2018001219A (ja)
RU (1) RU2018107052A (ja)
WO (1) WO2017018816A1 (ja)
ZA (1) ZA201801189B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020211584A1 (zh) * 2019-04-19 2020-10-22 海正生物制药有限公司 组合物中泊洛沙姆188的检测方法
KR20220082975A (ko) * 2020-12-10 2022-06-20 주식회사 삼양홀딩스 재건 시간을 단축할 수 있는 고분자 미셀 나노입자의 제조 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0180334B1 (ko) 1995-09-21 1999-03-20 김윤 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
KR100360827B1 (ko) * 1999-08-14 2002-11-18 주식회사 삼양사 난용성 약물을 가용화하기 위한 고분자 조성물 및 그의 제조방법
CN1233420C (zh) 2000-05-12 2005-12-28 株式会社三养社 通过嵌段共聚物的相分离制备聚合物胶束的方法
US7217770B2 (en) * 2000-05-17 2007-05-15 Samyang Corporation Stable polymeric micelle-type drug composition and method for the preparation thereof
CN1303155C (zh) * 2001-10-18 2007-03-07 株式会社三养社 具有改进稳定性的聚合物胶束组合物
US9801818B2 (en) * 2007-12-31 2017-10-31 Samyang Biopharmaceuticals Corporation Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
KR101024742B1 (ko) * 2007-12-31 2011-03-24 주식회사 삼양사 탁산 함유 양친성 블록 공중합체 미셀 조성물 및 그 제조방법
US8853351B2 (en) * 2007-12-31 2014-10-07 Samyang Biopharmaceuticals Corporation Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof
EP2201935B1 (en) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymeric micelle composition containing a poorly soluble drug and preparation method of the same
CN101444510B (zh) 2008-12-31 2011-03-09 南京卡文迪许生物工程技术有限公司 含有伏立康唑的药物制剂及其制备方法
CN104758256B (zh) * 2014-02-14 2016-05-04 苏州海特比奥生物技术有限公司 一种多西他赛纳米聚合物胶束冻干制剂及其制备方法

Also Published As

Publication number Publication date
HK1249439A1 (zh) 2018-11-02
CN111574702A (zh) 2020-08-25
ZA201801189B (en) 2019-01-30
JP6605706B2 (ja) 2019-11-13
MX2018001219A (es) 2018-04-24
WO2017018816A1 (en) 2017-02-02
CN106559983A (zh) 2017-04-05
JP2018521094A (ja) 2018-08-02
CA2993920A1 (en) 2017-02-02
KR101748191B1 (ko) 2017-06-19
RU2018107052A3 (ja) 2019-08-28
IL257185A (en) 2018-03-29
EP3328434A1 (en) 2018-06-06
RU2018107052A (ru) 2019-08-28
AU2016299544A1 (en) 2018-03-08
KR20170015198A (ko) 2017-02-08
EP3328434A4 (en) 2019-03-13

Similar Documents

Publication Publication Date Title
PH12017502255A1 (en) Nrf2 regulators
GEP20217239B (en) Pharmaceutical composition
BR112018006696A2 (pt) métodos e sistemas para obter óleo a partir de uma composição de vinhoto
EP3225662A4 (en) One-pack addition curable silicone composition, method for storing same, and method for curing same
BR112016014880A2 (pt) Composição farmacêutica incluindo palonosetron
EP3310439A4 (en) PHARMACEUTICAL COMPOSITIONS FOR ANESTHESIOLOGICAL APPLICATIONS
GEP201706760B (en) Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same
GEP20217240B (en) Pharmaceutical composition
MX2017013073A (es) Inhibidores de grelina o-aciltransferasa.
EP3275454A4 (en) Pharmaceutical composition containing silybin, ve and l-carnitine
MX2017013072A (es) Inhibidores de grelina o-aciltransferasa.
PL3278801T3 (pl) Kompozycja farmaceutyczna zawierająca mirabegron
TN2018000057A1 (en) Compounds useful for inhibiting ror-gamma-t.
HRP20200104T8 (hr) Novi heterociklični spoj, metoda za pripremu istog, i farmaceutska kompozicija koja sadrži isto
JO3456B1 (ar) فيروتيوكسيتين بيروجلوتامات
IL263476B (en) A compound with a high concentration of immunoglobulin for medical use
EP3275457A4 (en) Pharmaceutical composition containing silybin
EP3329271A4 (en) METHOD FOR ANALYZING RELATED SUBSTANCES OF A PHARMACEUTICAL COMPOSITION CONTAINING A POLYMER TRANSPORTER
EP3296285A4 (en) Ester-based compound, composition containing same, method for preparing same, and resin composition containing same
BR112018001736A2 (pt) ?composição farmacêutica com micela polimérica?
BR112018001725A2 (pt) composição farmacêutica com micela polimérica.
EP3244895A4 (en) Novel pharmaceutical composition
BR112018067656A2 (pt) composições farmacêuticas anti-abuso
EP3330378A4 (en) MODIFIED siRNA, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
EP3305283A4 (en) STABILIZED PHARMACEUTICAL COMPOSITION AND PROCESS FOR PREPARING THE SAME

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]